Sequoia Financial Advisors LLC Sells 53,069 Shares of The Clorox Company (NYSE:CLX)

Sequoia Financial Advisors LLC reduced its stake in The Clorox Company (NYSE:CLX – Free Report) by 87.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,915 shares of the company’s stock after selling 53,069 shares during the period. Sequoia Financial Advisors LLC’s holdings in Clorox were worth $1,252,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CLX. American Century Companies Inc. boosted its stake in Clorox by 18.0% during the first quarter. American Century Companies Inc. now owns 8,320 shares of the company’s stock valued at $1,157,000 after buying an additional 1,269 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in Clorox by 6.8% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 16,465 shares of the company’s stock valued at $2,289,000 after buying an additional 1,044 shares during the period. Cibc World Market Inc. boosted its stake in Clorox by 276.6% during the first quarter. Cibc World Market Inc. now owns 9,318 shares of the company’s stock valued at $1,295,000 after buying an additional 6,844 shares during the period. Dimensional Fund Advisors LP raised its position in Clorox by 0.8% during the first quarter. Dimensional Fund Advisors LP now owns 683,818 shares of the company’s stock valued at $95,073,000 after purchasing an additional 5,145 shares in the last quarter. Finally, Blair William & Co. IL raised its position in Clorox by 81.1% during the first quarter. Blair William & Co. IL now owns 24,525 shares of the company’s stock valued at $3,410,000 after purchasing an additional 10,981 shares in the last quarter. Institutional investors own 79.37% of the company’s stock.

Get Clorox alerts:

Clorox Stock Down 1.0 %

Shares of NYSE:CLX opened at $156.45 on Tuesday. The Clorox Company has a 1 year low of $124.58 and a 1 year high of $178.21. The company has a market cap of $19.34 billion, a PE ratio of 269.75, a P/E/G ratio of 2.21 and a beta of 0.30. The company has a debt-to-equity ratio of 14.40, a current ratio of 0.87 and a quick ratio of 0.51. The stock’s 50-day moving average is $161.03 and its 200 day moving average is $155.10.

Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Tuesday, May 2nd. The company reported $1.51 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.29. The business had revenue of $1.92 billion for the quarter, compared to analysts’ expectations of $1.82 billion. Clorox had a return on equity of 114.67% and a net margin of 1.03%. The business’s revenue was up 5.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.31 EPS. Sell-side analysts anticipate that The Clorox Company will post 4.56 EPS for the current year.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research reports. StockNews.com initiated coverage on Clorox in a research report on Thursday, May 18th. They set a “hold” rating on the stock. Barclays raised their price target on Clorox from $118.00 to $124.00 in a research report on Sunday, May 14th. Raymond James lifted their price objective on Clorox from $165.00 to $185.00 in a report on Wednesday, May 3rd. Wells Fargo & Company lifted their price objective on Clorox from $145.00 to $150.00 in a report on Wednesday, May 3rd. Finally, Bank of America lifted their price objective on Clorox from $130.00 to $140.00 in a report on Wednesday, May 3rd. Seven investment analysts have rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $148.54.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

• Five stocks we like better than Clorox
• 3 Stocks that Analysts Continue to Upgrade into Earnings Season
• Meta Threads Its Way To New Heights 
• Helen of Troy and NanoString Technologies Trade Set-ups
• Profit Taking Hits Home for Specialty Retailers
• The 3 Hot Sectors To Watch During The Summer Reporting Season

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.